Concepedia

Adèle Mangelinck

AM

Statistics

Publications

8

Citations

160

H-Index

8

Active since

2019

Affiliations

Université Paris-Saclay(Current)

Centre National de la Recherche Scientifique

Inserm

CEA Paris-Saclay

Commissariat à l'Énergie Atomique et aux Énergies Alternatives

Adèle Mangelinck is an author at Université Paris-Saclay specializing in molecular biology, life sciences, and histone variant effects.

ORCID

Publications per year

2019–2024

8

Publications

8

Reduced RNA turnover as a driver of cellular senescence

Nowsheen Mullani, Yevheniia Porozhan, Adèle Mangelinck et al. · Life Science Alliance · 2021 · 32 citations · Full text

, , +17

MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma

Adèle Mangelinck, Maria Eugénia Marques Da Costa, Bojana Stefanovska et al. · Scientific Reports · 2019 · 31 citations · Full text

, , +17

Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma

Adèle Mangelinck, Nadia Habel, Audrey Mohr et al. · Cancers · 2021 · 22 citations · Full text

, , +17

Histone Variant H2A.J Is Enriched in Luminal Epithelial Gland Cells

Christophe E. Redon, Zoé Schmal, Gargi Tewary et al. · Genes · 2021 · 16 citations · Full text

, , +15

Characterization of CD4+ and CD8+ T cells responses in the mixed lymphocyte reaction by flow cytometry and single cell RNA sequencing

Adèle Mangelinck, Agathe Dubuisson, Étienne Becht et al. · Frontiers in Immunology · 2024 · 16 citations · Full text

, , +17

1–5 of 8